Adaptin Bio, Inc.
APTN
OTC PK
Recommendation
Dividend Power Score
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
--
Corporate Info
Website
Phone Number
(888) 609-1498
Address
3540 Toringdon Way
Suite 200
#250
Charlotte, NC 28277
Suite 200
#250
Charlotte, NC 28277
Country
United States
Year Founded
2021
Details
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Employees
Business Description
Adaptin Bio, Inc., a biotechnology company, develops drug delivery technologies to deliver drugs and other compounds directly to target destinations within the body. It provides Brain Bispecific T cell Engager platform, a bispecific antibody technology to target and treat intracerebral malignancies, such as gliomas. It develops APTN-101, a proprietary epidermal growth factor receptor variant III to eliminate malignant glioma tumors in a range of aggressive preclinical tumor models. It caters to patients with oncology, CNS, autoimmune, and cardiovascular conditions as well as healthcare professionals, researchers, and biopharma partners. The company was founded in 2021 and is based in Charlotte, North Carolina.